Form 4: Exelon SVP Controller Reports Share Transactions
Insider Transaction Report
Exelon's SVP, Controller & Tax, Robert A. Kleczynski, reported the vesting and exercise of restricted stock units and performance shares, alongside related tax withholdings and sales.
Summary
- Robert A. Kleczynski, SVP, Controller & Tax at Exelon Corp, reported transactions on February 2, 2026, involving the company's common stock and derivative securities.
- He acquired a total of 12,287 shares of Exelon common stock through the exercise of previously granted Restricted Stock Units (RSUs) and Performance Shares. This included 1,474 shares from 2023 RSUs, 1,684 shares from 2024 RSUs, 2,110 shares from 2025 RSUs, and 7,019 shares from 2023-2025 Performance Shares.
- Concurrently, 3,768 shares were disposed of at $43.91 for tax withholding, and an additional 4,963 shares were sold at the same price of $43.91.
- New equity awards granted included 5,673 2026 Restricted Stock Units and 7,019 2023-2025 Performance Shares.
- Following these transactions, Kleczynski's direct beneficial ownership of common stock is 44,681 shares.
- His balance of deferred phantom share equivalents was 1,798 as of December 31, 2025, which includes 62 shares accrued through dividend reinvestment during 2025.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing. While there are sales, they are largely offset by significant vesting and new grants, indicating ongoing executive alignment with shareholder interests through equity compensation.
Positives
- Vesting and exercise of 2023, 2024, and 2025 Restricted Stock Units and 2023-2025 Performance Shares, resulting in the acquisition of 12,287 shares of common stock.
- Grant of new equity awards, including 5,673 2026 Restricted Stock Units and 7,019 2023-2025 Performance Shares, indicating continued long-term incentive alignment.
- Accumulation of additional shares through automatic dividend reinvestment for RSUs and deferred phantom share equivalents.
Negatives
- Disposal of 3,768 shares of common stock at $43.91 for tax withholding purposes.
- Sale of 4,963 shares of common stock at $43.91.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider transaction filings like this Form 4 are routine disclosures for executive compensation, reflecting the standard practice of granting equity awards as part of long-term incentive plans in the utility sector. The combination of vesting, tax-related sales, and new grants is typical for executives managing their equity holdings.
Related Party Transactions
- Robert A. Kleczynski, SVP, Controller & Tax, engaged in transactions involving Exelon common stock and derivative securities as part of his compensation plan.
Stakeholder Impact
- Shareholders: The transactions reflect standard executive compensation practices, aligning management's interests with shareholders through equity ownership, though some sales occurred.
- Employees: The filing details executive compensation, which may set a precedent or reflect the company's overall compensation philosophy.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | Balance date for deferred phantom share equivalents. |
| 02/02/2026 | Transaction date for vesting, exercise, acquisition, and disposal of common stock and derivative securities. |
| 02/04/2026 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThe filing details routine executive compensation activities, including the vesting of equity awards and associated sales for tax purposes. While there are sales, they are balanced by new grants and the overall increase in beneficial ownership from vested awards. This type of insider activity is generally expected and does not provide a strong signal for a 'buy' or 'sell' recommendation based solely on this filing. It suggests continued alignment of executive interests with the company's performance.
Keywords
Exelon, EXC, Form 4, Insider Trading, Restricted Stock Units, Performance Shares, Executive Compensation, Stock Transactions, Dividend Reinvestment, Deferred Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.